VisualDx vs ASCCP Management Guidelines

VisualDx is a visual reference tool for medical professionals that leverages AI technology and a comprehensive image atlas to support faster, more confident decisions, fewer unnecessary referrals and testing, and higher patient engagement and satisfaction. With VisualDx, clinicians can: • Build dynamic differentials that evolve as you think. • Use guided support to surface clinically relevant results. • Compare diagnoses to improve decisions for your patients. • Use our AI to take a picture of your patient’s skin condition to better understand morphology and possibilities. • Engage with patients by sharing pictures of skin that reflect their disease presentation. • Access therapy and testing recommendations across over 3,500 conditions. • Quickly recognize infectious diseases and travel-related illnesses with our public health resources. • Test your diagnostic skills with our image challenges and educational resources. • Earn 0.5 AMA PRA Category 1 Credits™ for internet point of care activity with every search. See why this award-winning clinical decision support system is being used in more than 2,300 hospitals, clinics, and medical schools by physicians, nurses, students, PAs, NPs, and other healthcare professionals worldwide. VisualDx requires a subscription. Terms of Use: https://www.visualdx.com/legal/acceptable-use-policy-notice Privacy Policy: https://www.visualdx.com/legal/privacy-policy/

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.